SIGA Stock Summary and Trading Ideas (Siga Technologies | NASDAQ:SIGA)

SIGA Technologies Inc a commercial-stage pharmaceutical company. The Company sells its product, TPOX oral TPOXX, also known as tecovirimat, Tecovirimat-SIGA, or TEPOXX (tecovirimat) in certain international markets, to the U.S. Government and international governments (including government-affiliated entities). The Company operates in one single operating and reportable segment, which includes all activities related to the sale of the Company's Oral and IV TPOXX as well as research and development services.

Siga Technologies trades on the NASDAQ stock market under the symbol SIGA.

As of March 30, 2026, SIGA stock price declined to $5.26 with 598,593 million shares trading.

SIGA has a beta of 1.43, meaning it tends to be more sensitive to market movements. SIGA has a correlation of 0.20 to the broad based SPY ETF.

SIGA has a market cap of $375.78 million. This is considered a Small Cap stock.

In the last 3 years, SIGA traded as high as $12.83 and as low as $4.22.

The top ETF exchange traded funds that SIGA belongs to (by Net Assets): VTI, AVUV, IWM, VXF, DFAT.

SIGA has underperformed the market in the last year with a return of +5.2%, while the SPY ETF gained +12.7%. In the last 3 month period, SIGA fell short of the market, returning -16.1%, while SPY returned -8.2%. However, in the most recent 2 weeks SIGA has outperformed the stock market by returning 0.0%, while SPY returned -4.3%.

SIGA support price is $5.12 and resistance is $5.48 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that SIGA shares will trade within this expected range on the day.